Clinical trial Recruiting at 2 sites Observational

Vision outcomes after PTK-PRK using the CZM MEL 90 excimer laser

Official title: Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser for Verification of Predicted Refractive Outcome Using EpiMaster Software Considering Epithelial Remodelling

Run by London Vision Clinic · NCT06996353 · Data updated 2026-11-12

This project will see if the EpiMaster app's predicted vision results match actual outcomes after PTK-PRK using the CZM MEL 90 laser for people with myopia or myopia plus astigmatism.

Quick facts

Study typeObservational
SexAll
Enrollment150 (estimated)
SponsorLondon Vision Clinic
Academic / other
Locations2 sites (Chandigarh, Punjab Haryana and 1 other locations)
StatusRecruiting
StartedMay 26, 2025
Main results expectedNovember 2026
Study endsJune 2027
Registry record updatedJanuary 9, 2026
Trial IDNCT06996353 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with myopia (with or without astigmatism) scheduled for PTK-PRK with the CZM MEL 90 laser who can provide informed consent and complete follow-up visits.

Probably not a fit

Patients with ocular conditions excluded by the CZM MEL 90 user manual or those not undergoing PTK-PRK (including non-myopic refractive errors) are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational investigation collects routine postoperative clinical data from patients who undergo PTK-PRK with the CZM MEL 90 excimer laser and compares those results to preoperative predictions produced by the EpiMaster software. EpiMaster is not used to guide treatment in this project; its predictions are compared retrospectively to clinical refractive outcomes. Inclusion and exclusion follow the CZM MEL 90 user manual, and enrolled patients must be able to consent and complete scheduled follow-up visits. The work is sponsored by London Vision Clinic with Optana GmbH as collaborator and is conducted at participating eye clinics in India.

Why it matters

Potential benefit: If successful, this could improve clinicians' ability to predict refractive outcomes after PTK-PRK, leading to more accurate treatment planning and clearer patient expectations.

How similar studies have gone: Prediction tools and nomograms for refractive surgery have shown moderate success, but direct validation of the EpiMaster application specifically for PTK-PRK is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Inclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors
* Patient present with myopic or myopic and astigmatic error
* Patient will be able to understand the patient information and willing to sign an informed consent
* Patient will be willing to comply with all follow-up visits and the respective examinations

Exclusion Criteria:

* Exclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors

Where it's running

  • Pro Sight Eye Hospital
    Chandigarh, Punjab Haryana, India
    Recruiting
  • Uma Eye Clinic
    Chennai, Tamil Nadu, India
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.